Owned by the Association for International Promotion & Study in Tumors (APSIT)
Cellular based immunotherapy for primary liver cancer
Primary liver cancer (PLC) is a common malignancy with high morbidity and mortality. Poor prognosis and easy recurrence on PLC patients calls for optimizations of the current conventional treatments and the ex...